Sutimlimab (C1S) Antibody, Monoclonal
| Code | Size | Price |
|---|
| PSI-10-884-0.1mg | 0.1mg | £657.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Antibody Isotype: IgG4-kappa
Antibody Clonality: Recombinant Antibody
Regulatory Status: RUO
Shipping:
blue ice
Storage:
Store at -80˚C
Documents
Further Information
Additional Names:
BIVV009,IPN-009,TNT009
Background:
Sutimlimab is anti-C1s antibody, and studies have shown that it can significantly increase hemoglobin levels in patients with primary cold agglutinin disease. Cold agglutinin disease (CAD) is an acquired autoimmune hemolytic anemia (AIHA). In cold environments, clinical symptoms related to erythrocyte agglutination occur in cold parts of the body (for example, net Cyanosis or cyanosis of extremities) and hemolytic anemia.
Buffer:
PBS buffer pH7.5
Concentration:
batch dependent
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Immunogen:
Chimeric,Humanized / C1S [Homo sapiens]
NCBI Organism:
homo sapiens
Purification:
>95%
Research Area:
Drug Analogues
Source:
CHO cells
User NOte:
Optimal dilutions for each application to be determined by the researcher.